# Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma

> **NCT02697344** · PHASE1 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 10 (actual)

## Conditions studied

- Recurrent Plasma Cell Myeloma

## Interventions

- **DRUG:** Dexamethasone
- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Lenalidomide
- **OTHER:** Pharmacological Study
- **DRUG:** R-(-)-Gossypol Acetic Acid

## Key facts

- **NCT ID:** NCT02697344
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04-14
- **Primary completion:** 2018-10-26
- **Final completion:** 2023-12-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-12-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02697344

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02697344, "Gossypol Acetic Acid With Lenalidomide and Dexamethasone in Treating Patients With Relapsed Symptomatic Multiple Myeloma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02697344. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*